Latest atopic dermatitis Stories

2011-07-11 08:00:00

MAPLE GROVE, Minn., July 11, 2011 /PRNewswire/ -- Today Upsher-Smith Laboratories, Inc. announced the launch of Trianex(TM) 0.05% (Triamcinolone Acetonide Ointment), a prescription topical corticosteroid offering the feel of a cream with the strength of an ointment.

2011-05-26 06:00:00

FLORHAM PARK, N.J., May 26, 2011 /PRNewswire/ -- Today, Gerber Products Company, a part of the Nestle family, announced that Gerber® Good Start® milk-based formulas are the first and only infant formulas that meet the criteria for a qualified health claim.

2011-05-02 20:36:50

Atopic dermatitis is a form of eczema that is caused by an inappropriate inflammatory response in the skin.

2011-03-10 02:59:00

LUXEMBOURG, March 10, 2011 /PRNewswire/ -- Creabilis SA, a clinical stage European biotechnology company addressing unmet medical needs in dermatology, today announced positive results from its Phase IIa study of its lead product CT327 in psoriasis vulgaris. CT327 is a novel topically applied TrkA kinase inhibitor developed using Creabilis' LSE (Low Systemic Exposure) technology.

2011-02-22 07:30:00

CUMBERLAND, R.I., Feb. 22, 2011 /PRNewswire/ -- Onset Dermatologics, a PreCision Dermatology company and a leader in developing and commercializing novel, prescription products for improving skin health, today announced the launch of the HylatopicPlus-Aurstat(TM) Kit.

2011-02-16 15:53:51

The first study of its kind in the world — involving 336 children aged between six months and 16 years old — has shown that installing a water softener for three months brings no additional relief for eczema sufferers.

2011-02-16 10:51:00

SAN FRANCISCO, Feb. 16, 2011 /PRNewswire/ -- Vista Partners announced today that it has updated coverage on Oculus Innovative Sciences, Inc., (Nasdaq: OCLS) and maintains its $3.81 target price.

2011-02-09 03:59:00

OXFORD, England, February 9, 2011 /PRNewswire/ -- Circassia Ltd, a specialty biopharmaceutical company focused on allergy, today announced that it has acquired the worldwide development and commercialization rights to the novel topical therapeutic for psoriasis and atopic dermatitis, PAP-1. Circassia acquired the rights to the proprietary molecule from Airmid Inc, for an undisclosed upfront sum plus milestone payments and royalties on future product sales. PAP-1 is one of the most potent...

2011-02-04 08:00:00

Preventative tips may help minimize risks NEW ORLEANS, Feb.

2011-02-04 08:00:00

New guidelines stress the need for proper diagnosis to confirm allergy NEW ORLEANS, Feb. 4, 2011 /PRNewswire-USNewswire/ -- Atopic dermatitis, one of the most common forms of eczema in this family of inflammatory skin diseases, is a chronic disease marked by red, cracked and itchy skin.

Word of the Day
  • A person in a secondary role, specifically the second most important character (after the protagonist).
The word 'deuteragonist' comes from a Greek word meaning 'an actor of second-class parts'.